Article
Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype.
Journal of cardiovascular pharmacology - 1 Dec 2012
Mukherjee Kamalika, Gitlin Jonathan M, Loftin Charles D
Abstract excerpt
Abdominal aortic aneurysms (AAAs) are a chronic condition that often progress over years to produce a weakened aorta with increased susceptibility for rupture, and currently, there are no pharmacological treatments available to slow disease progression. AAA development has been characterized by increased expression of cyclooxygenase-2 (COX-2), and inactivation of COX-2 before disease initiation reduces AAA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
